Related Experiment Video
Updated: Aug 5, 2026
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Anthraquinone-Loaded Liposomes for TAM Reprogramming in Triple-Negative Breast Cancer: Mechanistic Rationale,
Limin Zhai1, Juan Liu1, Lizhen Mu1
1Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China.
Anthraquinone-loaded liposomes show promise for reprogramming tumor-associated macrophages in triple-negative breast cancer. This approach could enhance immune responses and overcome therapeutic resistance, offering a new strategy beyond standalone cytotoxic treatments.
Area of Science:
- Oncology
- Immunology
- Nanomedicine
Background:
- Triple-negative breast cancer (TNBC) is aggressive with limited treatments and variable response to immunotherapy.
- Therapeutic resistance in TNBC is linked to myeloid immunosuppression, particularly tumor-associated macrophages (TAMs) that hinder anti-cancer immunity.
- Anthraquinones show potential for TAM reprogramming but face formulation challenges like poor solubility and toxicity.
Purpose of the Study:
- To review the potential of anthraquinone-loaded liposomes for TAM reprogramming in TNBC.
- To explore the mechanistic rationale, formulation strategies, and translational challenges.
- To assess their role as immune microenvironment recalibration platforms.
Main Methods:
- Literature review integrating mechanistic insights, delivery logic, and formulation determinants.
- Analysis of anthraquinone compounds (emodin, aloe-emodin, rhein, chrysophanol) and their effects on TAMs.
- Evaluation of liposomal delivery systems for improved pharmacokinetics and targeted delivery.
Main Results:
- Liposomal delivery can overcome anthraquinones' poor solubility, biodistribution, and toxicity issues.
- Liposomes enhance TAM uptake and intracellular release of anthraquinones.
- Key formulation factors include lipid composition, lamellarity, and responsive release mechanisms.
Conclusions:
- Anthraquinone-loaded liposomes are promising for recalibrating the immune microenvironment in TNBC.
- They are better suited as synergistic agents in combination therapy than as standalone treatments.
- Further research into clinically relevant formulations and developability is warranted.
